Alexion to Present at Upcoming Investor Conferences

NEW HAVEN, Conn.--(BUSINESS WIRE)-- Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that management will present at two upcoming investor conferences:

Morgan Stanley Global Healthcare Conference in New York on Tuesday, September 13, 2016 at 9:10 a.m., Eastern Time.

LEERINK Partners Roundtable Series: Rare Disease & Immuno-Oncology in New York on Wednesday, September 28, 2016 at 11:35 a.m., Eastern Time.

An audio webcast of each presentation will be available live. You can access the webcasts at: http://ir.alexionpharm.com. An archived version of the remarks will also be available through the Company’s website for a limited time following the conference.

[ALXN-G]

View source version on businesswire.com: http://www.businesswire.com/news/home/20160906005005/en/

Alexion Pharmaceuticals, Inc.
Elena Ridloff, CFA
Vice President, Investor Relations
(475) 230-3601

Source: Alexion Pharmaceuticals, Inc.

You May Also Be Interested In

• SungEel HiTech Implements Rockwell Automation's PlantPAx(R) DCS for Eco-Friendly Battery Recycling
• Silver Hammer Announces Acquisitions of Stroud Resources and Silvermark Resources and Brokered Financing; Eric Sprott to Become Cornerstone Shareholder
• Ecrypt Inc. Names Finance Industry Veteran Jared Grigg to Newly Created Position of Senior Vice President, Partnerships & Acquisitions